The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / January / Decoding RNA Expression in Cancer Data
Oncology Software and hardware Genetics and epigenetics Technology and innovation Molecular Pathology

Decoding RNA Expression in Cancer Data

New software links miRNA regulation with disease classification

01/23/2026 News 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

To introduce RNACOREX, a computational tool for identifying disease-associated RNA regulatory networks and classifying patient samples based on gene expression data.

Approach:
    Key Findings:
    • RNACOREX achieved classification performance comparable to machine learning methods like random forest and support vector machines.
    • The tool provides interpretable visualizations of RNA interactions, highlighting both recurrent and tissue-specific interactions across cancers.
    Interpretation:

    RNACOREX facilitates the exploration of RNA regulation in cancer, linking expression patterns to clinical outcomes while maintaining interpretability.

    Limitations:
    • RNACOREX is a research tool and does not establish clinical utility on its own.
    • The effectiveness of the tool is dependent on the quality of the underlying databases and expression data.
    Conclusion:

    RNACOREX offers a structured approach for analyzing RNA interactions in cancer, aiding in biomarker discovery and understanding regulatory pathways.

    Sources:
    • PLOS Computational Biology

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.